| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.5423 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 58.7223 | 63 |
| GSM780709 | Untreated after 4 days (C3_1) | 84.6349 | 73 |
| GSM780719 | Untreated after 4 days (C1_2) | 62.8458 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 56.8354 | 62 |
| GSM780721 | Untreated after 4 days (C3_2) | 89.6048 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 60.5897 | 65 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 62.5811 | 66 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 55.3178 | 60 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 56.0387 | 61 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.0755 | 56 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.8986 | 54 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 61.8767 | 66 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 60.3352 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 52.6632 | 55 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 64.1531 | 67 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 60.1897 | 65 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 70.2478 | 69 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 72.0687 | 70 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 66.1119 | 68 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 55.7166 | 60 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 66.2737 | 68 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 64.1581 | 67 |